| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | -9.22% | — | — | — | — |
| 14d | 1 | +100.00% | -6.91% | — | — | — | — |
| 30d | 1 | +100.00% | -11.29% | -1.73% | -9.56% | -9.56% | — |
| 60d | 1(1 pending) | — | — | — | — | — | — |
| 90d | 1(1 pending) | — | — | — | — | — | — |
| 180d | 1(1 pending) | — | — | — | — | — | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 8,543 | $4.26 | $36.4K | 167,750 | Jun 30, 2026 | Jul 1, 2026 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 16,961 | $4.29 | $72.8K | 176,293 | May 12, 2026 | May 13, 2026 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 1,552,769 | — | — | 1,552,769 | Oct 29, 2025 | Oct 31, 2025 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 193,254 | — | — | 193,254 | Aug 14, 2025 | Aug 14, 2025 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 352,800 | — | — | 352,800 | Aug 14, 2025 | Aug 14, 2025 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 1,073,249 | — | — | 1,073,249 | Aug 12, 2025 | Aug 14, 2025 ↗ | View → |